Biocon CRO revenues jump as B-MS deal ramps up
Biocon contract research revenues jumped 20 per cent in the fourth quarter as a relationship with B-MS ramped up.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Biocon contract research revenues jumped 20 per cent in the fourth quarter as a relationship with B-MS ramped up.